EVH - Evolent Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue434,950254,18896,878-
Cost of Revenue269,352151,27757,398-
Gross Profit165,598102,91139,480-
Operating Expenses
Research Development----
Selling General and Administrative195,666144,93670,98670,986
Non Recurring----
Others----
Total Operating Expenses491,886313,437135,550-
Operating Income or Loss-56,936-59,249-38,672-38,672
Income from Continuing Operations
Total Other Income/Expenses Net-19,868-178,284381,961-25,246
Earnings Before Interest and Taxes-56,936-59,249-38,672-
Interest Expense-3,636-247-247-247
Income Before Tax-76,404-237,533343,289-25,246
Income Tax Expense-6,637-10,75523,475-
Minority Interest35,427209,588285,238285,238
Net Income From Continuing Ops-69,767-226,778319,814-25,246
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-60,665-159,742332,494-25,246
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-60,665-159,742330,310-31,137